Natural ingredients from Chinese materia medica for pulmonary hypertension

被引:0
|
作者
ZHANG Jia-Rui [1 ]
OUYANG Xuan [1 ]
HOU Chi [1 ,2 ]
YANG Qi-Feng [1 ]
Wu Yingjun [3 ]
LU Wen-Ju [1 ]
LIU Chun-Li [1 ]
YANG Kai [1 ]
ZHONG Nan-Shan [1 ]
WANG Jian [1 ,4 ,5 ]
CHEN Yu-Qin [1 ]
机构
[1] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, Guangzhou Institute of Respi
[2] Section of Physiology, Division of Pulmonary, Critical Care and Sleep Medicine, University of California
[3] The Second Affiliated Hospital of Guangzhou medical university
[4] Division of Pulmonary and Critical Care Medicine, the People's Hospital of Inner Mongolia
[5] Department of Neurology, Guangzhou Women and Children's Medical Center
关键词
D O I
暂无
中图分类号
R259 [现代医学内科疾病];
学科分类号
100506 ;
摘要
Pulmonary hypertension(PH) is a severe pathophysiological condition characterized by pulmonary artery remodeling and continuous increases in pulmonary artery pressure, which may eventually develop to right heart failure and death. Although newly discovered and incredible treatment strategies in recent years have improved the prognosis of PH, limited types of effective and economical drugs for PH still makes it as a life-threatening disease. Some drugs from Chinese materia medica(CMM) have been traditionally applied in the treatment of lung diseases. Accumulating evidence suggests active pharmaceutical ingredients(APIs) derived from those medicines brings promising future for the prevention and treatment of PH. In this review, we summarized the pharmacological effects of APIs derived from CMM which are potent in treating PH, so as to provide new thoughts for initial drug discovery and identification of potential therapeutic strategies in alternative medicine for PH.
引用
收藏
页码:801 / 814
页数:14
相关论文
共 50 条